Here are the key takeaways from the discussion
Safety and tolerance of three probiotic strains in healthy infants: A multi-centre randomized, double-blind, placebo-controlled trial
Jastreboff et al., 2022), have been shown to be associated with lower risk of incident HF and to improve established severe HF (Sundstrm et al., 2017
Medically reviewed by Oghenefejiro Okifo | MD , Harvard Medical School | Henry Ford Hospital - Detroit, MI on August 19th, 2025
Scientifically Backed: Semaglutides role as a GLP-1 agonist is well-documented, with studies showing its benefits in weight loss, appetite reduction, improved insulin sensitivity, and cardiovascular protection
Pay attention to how you feel during and after workouts